|
|
News for Healthier Living
First-in-Class Therapy Targets "Undruggable" Protein in Hard-to-Treat Blood Cancers
A first-in-class therapy to target MYC, one of the most sought-after and difficult targets in cancer biology, showed promise in hard-to-treat blood cancers, according to a new preclinical study from The University of Texas MD Anderson Cancer Center published in Blood.
August 21, 2026
August 26 2026August 25 2026August 24 2026August 21 2026August 20 2026August 19 2026August 18 2026August 17 2026August 16 2026August 15 2026August 14 2026August 13 2026August 12 2026
|
|
|
|
|